Farah Smith
Family · Douglas, GANPI 1447616461
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 723 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 51 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 723 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- Pfizer$1K
- Amgen$1K
- Corcept Therapeutics$1K
- GSK$921
- plus $7K from 45 others
What the payments were for
- Food & beverage$14,25998%
- Education$3312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,590 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 110 | $109,163 |
| MounjaroTirzepatide | 88 | $105,895 |
| FarxigaDapagliflozin Propanediol | 115 | $101,928 |
| VraylarCariprazine Hcl | 47 | $69,076 |
| JardianceEmpagliflozin | 82 | $62,116 |
| LinzessLinaclotide | 90 | $59,220 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $40,313 |
| EliquisApixaban | 45 | $36,530 |
| JanuviaSitagliptin Phosphate | 48 | $33,669 |
| KerendiaFinerenone | 29 | $30,414 |
| TrulicityDulaglutide | 18 | $25,620 |
| MyrbetriqMirabegron | 45 | $23,464 |
| Repatha SureclickEvolocumab | 29 | $21,206 |
| XareltoRivaroxaban | 27 | $19,092 |
| GemtesaVibegron | 22 | $17,802 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Linzess, Creon, Synthroid | $1,446 | $141,594189 claims |
| Lilly USA, LLCMounjaro, Trulicity | $155 | $131,515106 claims |
| Novo NordiskOzempic, Rybelsus | $1,441 | $124,016125 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $743 | $120,231149 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $137 | $75,991107 claims |
| GSKTrelegy Ellipta | $921 | $40,31359 claims |
| PfizerEliquis | $1,318 | $36,53045 claims |
| MerckJanuvia | $124 | $33,66948 claims |
| BayerKerendia | $268 | $30,41429 claims |
| Astellas Pharma US IncMyrbetriq | $710 | $23,46445 claims |
| Johnson & JohnsonXarelto | $234 | $19,09227 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $181 | $17,80222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.
Other family in Douglas
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.